Korea Mulls Moves To Aid Smaller Pharma Firms
This article was originally published in PharmAsia News
Executive Summary
South Korea's Ministry of Food and Drug Safety has suggested steps to help small- and medium-sized pharma firms in the country overcome difficulties stemming from increased investment costs, lower drug prices and the MERS outbreak. The measures include forming a consultative group to discuss obstacles and mutual cooperation at the development and other stages.